Venous thrombotic risk in family members of unselected individuals with factor V Leiden
- PMID: 10896231
Venous thrombotic risk in family members of unselected individuals with factor V Leiden
Abstract
The factor V Leiden mutation (FVL) leads to a seven-fold increased risk of venous thromboembolism (VTE). In thrombophilic families. 25% of carriers have experienced thrombosis before the age of 40 years. Aim of our study was to assess the association of FVL with VTE in first-degree family members of unselected symptomatic and asymptomatic carriers of FVL. We tested 197 relatives of consecutive thrombosis patients with FVL and 36 relatives of asymptomatic carriers on the presence of FVL and the occurrence of VTE. The incidence of VTE in relatives with FVL of symptomatic carriers was 0.34%/year. This was similar to the incidence in relatives with FVL of asymptomatic carriers. Kaplan Meier analysis in relatives of symptomatic propositi showed that at the age of 58 years, thrombosis-free survival was reduced to 75% in carriers and 93% in non-carriers (P <0.05). Carriers of FVL had a three times higher thrombotic risk than non-carriers. In combination with environmental risk factors, FVL clearly adds to the risk of VTE. The thrombotic incidence rate in these unselected relatives with FVL. however, is considerably lower than was seen in carriers of thrombophilic families (1.7%/year). Therefore, special care should be paid to individuals with a positive family history of venous thrombosis while exposed to these risk factors.
Similar articles
-
Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.Thromb Haemost. 2006 Dec;96(6):744-9. Thromb Haemost. 2006. PMID: 17139368
-
Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?Thromb Haemost. 1997 Dec;78(6):1480-3. Thromb Haemost. 1997. PMID: 9423798
-
Incidence of venous thromboembolism in families with inherited thrombophilia.Thromb Haemost. 1999 Feb;81(2):198-202. Thromb Haemost. 1999. PMID: 10063991
-
The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.Haematologica. 2007 Aug;92(8):1107-14. doi: 10.3324/haematol.10234. Haematologica. 2007. PMID: 17650440
-
Inherited thrombophilia and venous thromboembolism.Semin Thromb Hemost. 2006 Oct;32(7):700-8. doi: 10.1055/s-2006-951298. Semin Thromb Hemost. 2006. PMID: 17024597 Review.
Cited by
-
Inherited risk factors for venous thromboembolism.Nat Rev Cardiol. 2014 Mar;11(3):140-56. doi: 10.1038/nrcardio.2013.211. Epub 2014 Jan 14. Nat Rev Cardiol. 2014. PMID: 24419261 Review.
-
Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.J Thromb Thrombolysis. 2016 Jan;41(1):92-128. doi: 10.1007/s11239-015-1309-0. J Thromb Thrombolysis. 2016. PMID: 26780741 Free PMC article.
-
Venous thromboembolism and sarcoidosis: co-incidence or coexistence?Cent Eur J Immunol. 2015;40(4):477-80. doi: 10.5114/ceji.2015.56972. Epub 2016 Jan 15. Cent Eur J Immunol. 2015. PMID: 26862313 Free PMC article. Review.
-
Inherited thrombophilia: key points for genetic counseling.J Genet Couns. 2007 Jun;16(3):261-77. doi: 10.1007/s10897-006-9069-9. Epub 2007 May 1. J Genet Couns. 2007. PMID: 17473965 Review.
-
Testing for thrombophilia: an evidence-based approach.Postgrad Med J. 2006 Nov;82(973):699-704. doi: 10.1136/pgmj.2006.048090. Postgrad Med J. 2006. PMID: 17099087 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical